WiSeed

Dianosic was founded in 2017 and develops cutting-edge solutions to resolve patient compliance challenges in Ear, Nose and Throat (ENT) conditions such as chronic allergic rhinitis and chronic sinusitis. Dianosic’s strategic goal is to establish new standards of care in chronic rhinitis and chronic sinusitis with its drug-eluting Active Resorbable Scaffold (ARIS). This breakthrough formulation is developed with world renowned resorbable polymers experts. This long acting (6 to 12 months), steady releasing, patients and physicians' friendly, has the potential to establish new treatment paradigms. Noteworthy, our ARIS platform creates immense opportunities to create other verticals, especially in the field of chronic migraine and facial pain.

BioIntrant provides agricultural productivity improving services. They also provide biotechnology, agriculture, agronomy, microbiology, biostimulator, bioinformatics, and genomics services.

VistaCare is an innovative French VSE specializing in medical devices. They develop, manufacture, and distribute medical devices for the treatment of the critical phase of acute and chronic wounds. The company's technology enhances the quality of life and the care pathway for patients with wounds, as well as simplifying the daily lives of caregivers by drastically lowering treatment times and hospital stays.

SPARTHA Medical develops invisible, eco-friendly, personalized and biocompatible coatings addressed to medical devices and consumer products to protect users from microbial and inflammatory risks. Our innovation stands on natural biopolymers which supramolecular assembly confers antibacterial, antiviral and anti-inflammatory properties to any surface. We work basically with two different polyelectrolytes that do not need any further chemical procedure than mix to be effective. We can control the way they assemble (patented technology) to confer the versatile and multifunctional property we want to address depending on the field of work.

uvoji designs, develops, manufactures and markets all-in-one solutions for the treatment and disinfection of water at points of use and of surfaces by UV LEDs. To meet the major challenges of access to drinking water and provide technological solutions to the urgent needs of point-of-use water treatment, we launched the Oji Safe, Oji Pure and Oji Reuse products. Our solutions are used notably by the French Red Cross for its operations. In response to the Covid pandemic, we developed the Uvo Care. Uvo Care is the disinfection box, Made in France, for all types of masks and everyday objects. The essential ally for resuming your professional activities in complete safety. It has been tested and approved by independent laboratories and kills over 99.999% of viruses and bacteria in just seconds (including SARS-COV2 virus).

LUMI'IN is a designer, assembler, and distributor of solar lighting systems. They provide products that include solar, hybrid, autonomous, and intelligent lighting systems. An online inquiry form is available on the company's website.

GULPLUG is the new era of electrical connections. With a safe, magnetic hold and water-resistant functionality, it's an innovative smart plug designed to make everyday connections easier. GULPLUG combines Energy Efficiency with the Internet of Things, creating endless possibilities for electrical connections. Our products are ideal for a wide range of industries and products where safety, convenience, and energy savings are highly valued. We offer co-innovation services in order to help design and adapt gulplug products to your needs.

Today 1 women on 8 has a breast cancer, 40% of them will have a mastectomy to cure cancer and only 14% of them will have reconstruction because actual technics does no fit for breast reconstruction. That’s why LATTICE MEDICAL develops the implantable device MATTISSE which answer to clinical and societal issues and allow women to get back their bodies and life. MATTISSE implant allows a natural reconstruction by regenerating autologous adipose tissues, custom reconstruction thanks to 3D printing and single surgery due to fully biodegradable material, which fully disappear after reconstruction. We aim in long term to replace silicon-based implant by our technology.

ffly4u is a low frequency european locating service for reusable assets based on a new low cost technology. ffly4u is on the European leaders of embedded information on B2B mobile assets. ffly4u solution consists of 3 independent pilars: a device to fix to the mobile asset, a LPWAN connectivity (wireless and low speed) as SIGFOX and LoRa for data transmission and a platform-data powered by ThingWorx (PTC) for data recovery.

Levels3D is a startup company that specializes in 3D and augmented reality solutions and edits real-time 3D scan software. It develops a 3D scanning application on the next generation tablets, equipped with a depth sensor and it is designed for consulting firms, architects, general contractors, and space designers. The company provides its users with MyCaptR, a 3D scanning solution for professionals and Smart Glasses-ERDF, a demonstrator on tablet and a prototype augmented reality vision device. Levels3D is headquartered in France and the company was founded in 2012 by Yannick Folliard.

VIRAGE-VIAGER aims to develop intergenerational savings and give seniors the financial means to age well through a innovative and equity-conscious solution.

PiLi biofabricates a sustainable alternative to create renewable inks to replace their toxic, non-biological, and non-recyclable versions. Pili was born from the reunion of a biologist, a designer, and a financial analyst at the biohacker space La Paillasse in Paris and with the creation of the first pen fed by bacteria. Its team is now dedicated to providing the colors from micro-organisms to offer a sustainable alternative to fossil resources.

Poietis is a biotechnology company specializing in the design of regenerative medicine therapies thanks to 4D laser bioprinting. It provides industrial stakeholders and researchers with a unique platform to design and manufacture bio-printed products for regenerative medicine, preclinical research and evaluating the efficacy of cosmetic products and ingredients. Poietis is currently developing 3D physiological models and has partnerships with major pharmaceutical and cosmetic groups. These tissue models allow for a more predictive in vitro assessment of the toxicity and the efficacy of candidate drugs and new cosmetic ingredients. Poietis has undertaken several projects with international leaders to develop complex bio-printed products such as the bioprinting of a hair follicle with L'Oréal (see Press Release). Poietis has developed its single-cell bioprinting platform to make tissue bioprinting processes compatible with the requirements of industrial production and the standards for manufacturing clinical products.

1Check is an innovative SaaS platform and mobile application designed to transform operations management in the hospitality sector. Founded in 2012 by industry experts, this specialized solution addresses the specific needs of housekeeping, maintenance, and management. With over 350 client sites across Europe, 1Check is a recognized leader, offering intuitive technology that enhances customer satisfaction, reduces staff movement, and improves working conditions.

Vectalys, expert in gene delivery based on lentiviral vectors, is a private biotech company founded by Pascale Bouillé in 2005. Today, Vectalys counts 25 full-time employees exclusively dedicated to providing lentiviral vectors, cell models, molecular biology strategies and supporting your projects. Vectalys aims to help scientists worldwide understand cellular and molecular mechanisms in order to discover new drugs and therapies. Vectalys has developed a state-of-the-art proprietary technology to provide the highest quality of lentiviral vectors for the transduction of hard-to-transfect cells like primary cells, stem cells and in vivo tissues. Vectalys high quality lentiviral vectors ensure 100% transduction efficiency and non-toxic transduction on any target cells, for example to create predictive models. Because each project is unique, the Vectalys team supports you by providing custom lentiviral vectors for the right application with your gene of interest. Vectalys is also the manufacturer of highly pure ready-to-use lentiviral vectors carrying fluorescent, bioluminescent or gene editing proteins. These products are distributed worldwide. Vectalys is committed to providing solutions that save your time and support your most ambitious projects.

SUNiBRAIN is the first photovoltaic cell cooling system for professionals. Imagine that you can slow the aging of solar cells and dramatically increase their performance. Rainwater cooling is a natural and durable solution that keeps panels clean and protected from temperatures. extremes while guaranteeing maximum photoelectric efficiency day after day and year after year. Our patented technology offers immediate profitability to solar power producers who are equipped. SUNiBRAIN ™ is compatible with absolutely all types of photovoltaic plants in France as elsewhere!

Algo Paint has managed to innovate by replacing fossil fuels with renewable local resources.

StayHome SAS develops and operates a real estate portage platform. Its solution allows private individuals to carry out a rental investment while assisting owners during financial difficulty. Through the platform owners sell their real estate temporarily to find capital for balancing their debts. The porter allows owners to remain a tenant in their property and to acquire it second time at a price and within the time allowed by a contract.

Poietis is a biotechnology company specializing in the design of regenerative medicine therapies thanks to 4D laser bioprinting. It provides industrial stakeholders and researchers with a unique platform to design and manufacture bio-printed products for regenerative medicine, preclinical research and evaluating the efficacy of cosmetic products and ingredients. Poietis is currently developing 3D physiological models and has partnerships with major pharmaceutical and cosmetic groups. These tissue models allow for a more predictive in vitro assessment of the toxicity and the efficacy of candidate drugs and new cosmetic ingredients. Poietis has undertaken several projects with international leaders to develop complex bio-printed products such as the bioprinting of a hair follicle with L'Oréal (see Press Release). Poietis has developed its single-cell bioprinting platform to make tissue bioprinting processes compatible with the requirements of industrial production and the standards for manufacturing clinical products.

Naio Technologies develops and markets machines for agriculture and viticulture. It features electric tools for weeding, hoeing, and harvesting that help farmers collect and harvest their products. The company specializes in agriculture, AI, robotics, and Agtech. Naio Technologies was founded in 2011 and headquartered in Midi-Pyrenees, France.

Founded in 2010 by 4 entrepreneurs, GAIDDON Software SAS is a simplified joint-stock company registered under French law with a share capital of 161,100 Euros. It is based in Toulouse, south of France. GAIDDON Software is integrated within the Toulouse Metropole business incubator since its creation. In 2011, the company gained the french label “Jeune Entreprise Innovante” from the ministry of higher education and research. It indicates that most of the work done by the company is an innovative research and development. This innovative work is our 3D environment builder technology from aerial/satellite imagery.

MyFeelBack develops a smart survey technology allowing businesses to know their customers like never before. We help large companies keep their customer databases continuously up-to-date, collect high-value customer insights, and trigger ultra-personalized marketing actions to boost sales conversion. With MyFeelBack, our customers can ask targeted questions or display messages to their users and visitors based on who they are and what they do. Customer knowledge is no longer a mystery. Ask questions, get insights and take actions.

Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need. It develops stand-alone inhibitors of bacterial metalloenzymes that can be combined with various antibiotics to restore their activity against the most critical pathogens. The company's novel inhibitor of bacterial Metallo ß-lactamases (“MBLs”) which will be combined with a carbapenem to fill an important gap in the treatment of drug-resistant infections. They develop a novel, safe and efficacious inhibitor of bacterial Metallo ß-lactamases to be combined with a carbapenem for the treatment of drug-resistant nosocomial infections. Antabio received a Wellcome Trust Seeding Drug Discovery Award. The company was founded in 2009 and is headquartered in Labege, France.

Intuiface is the market’s only no-code platform dedicated to the creation, integration, deployment, and analysis of interactive digital experiences for physical spaces. Over 1,600 companies across 70+ countries are connecting people to place using interactive options such as touch, RFID/NFC, computer vision, Web APIs, Internet of Things, and much more. It is an ISO 27001 Certified platform that can be used by any industry – including retail, hospitality, real estate, tourism, education – and for any intent – from digital signs to self-service kiosks and assisted selling.

Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need. It develops stand-alone inhibitors of bacterial metalloenzymes that can be combined with various antibiotics to restore their activity against the most critical pathogens. The company's novel inhibitor of bacterial Metallo ß-lactamases (“MBLs”) which will be combined with a carbapenem to fill an important gap in the treatment of drug-resistant infections. They develop a novel, safe and efficacious inhibitor of bacterial Metallo ß-lactamases to be combined with a carbapenem for the treatment of drug-resistant nosocomial infections. Antabio received a Wellcome Trust Seeding Drug Discovery Award. The company was founded in 2009 and is headquartered in Labege, France.

Noomeo, an innovative company, was created in 2007 with the goal of bringing solutions to companies who desire an access to 3D through systems that are both user friendly and ultra portable. Companies can now integrate “Non contact 3D digitization” in their process in a way that is simple, time efficient and inexpensive. Its in-house R&D efforts as well as its partnerships with research labs (LAAS – CNRS and Ecole des Mines of Albi-Carmeaux) allow Noomeo to bring new software and hardware solutions for 3D digitization which places it as a state of the art company in this field. Noomeo has developed OptiNumTM hardware solutions along with NumiSoft TM software solutions in order to create your 3D mock ups automatically.